Read Books Online and Download eBooks, EPub, PDF, Mobi, Kindle, Text Full Free.
International Prescription Drug Price Comparisons
Download International Prescription Drug Price Comparisons full books in PDF, epub, and Kindle. Read online International Prescription Drug Price Comparisons ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Book Synopsis International Prescription Drug Price Comparisons by : Andrew W. Mulcahy
Download or read book International Prescription Drug Price Comparisons written by Andrew W. Mulcahy and published by . This book was released on 2021 with total page 53 pages. Available in PDF, EPUB and Kindle. Book excerpt: The United States spends more on prescription drugs on a per capita basis than most other countries do. Understanding the extent to which drug prices are higher in the United States than in other countries-after accounting for differences in the volume and mix of drugs-is useful when developing and targeting policies to address both growth in drug spending and the financial impact of prescription drugs on consumers. Although several prior studies systematically compare drug prices in the United States with those in other countries, the most recent of these studies used data that are almost a decade old. This report summarizes findings related to international prescription drug price comparisons presented in prior studies and presents new price comparisons that are based on 2018 data-both overall results and narrower analyses on specific categories of drugs, such as brand-name originator drugs, unbranded generic drugs, biologics, and nonbiologic drugs. The report also presents results from sensitivity analyses using different methodological steps and assumptions, such as prices and volume aggregated at different levels and volume weights calculated in different ways. The findings indicate that 2018 drug prices in the United States were substantially higher than those in each of 32 comparison countries when considering all drugs together. Compared with all comparison countries combined, U.S. prices were 256 percent of those in other countries. Prices remained substantially higher than prices in other countries-but with a smaller difference than in our main results-when we adjusted U.S. prices downward based on published estimates of the relative differences between manufacturer and net prices for drugs. U.S. prices for most subsets of drugs, and particularly brand-name originator drugs, were higher than those in comparison countries. The one exception was unbranded generic drugs, for which U.S. prices were on average 84 percent of those in other countries.
Author :United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment Publisher : ISBN 13 : Total Pages :216 pages Book Rating :4.0/5 (18 download)
Book Synopsis International Prescription Drug Prices by : United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment
Download or read book International Prescription Drug Prices written by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment and published by . This book was released on 1993 with total page 216 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis The Right Price by : Peter J. Neumann
Download or read book The Right Price written by Peter J. Neumann and published by Oxford University Press. This book was released on 2021-05-06 with total page 312 pages. Available in PDF, EPUB and Kindle. Book excerpt: The US prescription drug business is a $500 billion industry whose rising prices carry profound consequences for patients, caregivers, employers and taxpayers across the nation. In the United States, average prices of leading brand-name drugs are two to four times higher than prices charged in other wealthy countries, raising questions as to what Americans are getting for the extra expense. On the other hand, healthy industry returns have arguably fueled life-saving innovation. With the advent of ever more targeted and powerful treatments, including cell- and gene-based therapies with multi-million-dollar price tags, the need for sensible drug pricing policies will only intensify. The Right Price sheds light on the controversial topic of drug pricing by providing an accessible guide to pharmaceutical markets and analytic techniques used to measure the value of drug therapies. It illustrates the need for value-based pricing through real-life stories of patients and their experiences with the drug industry and explains why simple solutions like price controls and the importation of cheaper drugs from other countries are problematic. This volume describes how researchers and policy makers have pursued drug valuation efforts in the past, and lays out a series of recommendations, based on years of shared author experience serving on national drug policy platforms, for how to further improve pharmaceutical value assessment in the United States. With unique industry insights and clear narrative, The Right Price unveils why the pricing of drugs continues to be so challenging and how public and private officials can create more informed policies to achieve the right balance between drug pricing and value.
Book Synopsis Price Comparisons for Pharmaceuticals by : Patricia Munch Danzon
Download or read book Price Comparisons for Pharmaceuticals written by Patricia Munch Danzon and published by American Enterprise Institute. This book was released on 1999 with total page 68 pages. Available in PDF, EPUB and Kindle. Book excerpt: Drug coverage for seniors is better addressed by private-sector plans than by forcing manufacturers to offer Federal Supply Schedule discounts to the retail sector.
Book Synopsis Prescription drugs : companies typically charge more in the united states than in canada by : DIANE Publishing Company
Download or read book Prescription drugs : companies typically charge more in the united states than in canada written by DIANE Publishing Company and published by DIANE Publishing. This book was released on 1994 with total page 64 pages. Available in PDF, EPUB and Kindle. Book excerpt: Examines the extent to which drug manufacturers charge more for the same products in the U.S. than abroad. Also, studied manufacturers' "factory prices" and identified the causes of any documented price differentials. Compares factory prices for the top 200 frequently dispensed prescription drugs sold in both the U.S. and the U.K. 7 charts and tables.
Book Synopsis Prescription Drugs by : United States. General Accounting Office
Download or read book Prescription Drugs written by United States. General Accounting Office and published by . This book was released on 1994 with total page 58 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis Prescription Drug Pricing: Background, Discount Programs and Cost Lowering Strategies by : Elias B. Toft
Download or read book Prescription Drug Pricing: Background, Discount Programs and Cost Lowering Strategies written by Elias B. Toft and published by Nova Snova. This book was released on 2020-03-13 with total page 248 pages. Available in PDF, EPUB and Kindle. Book excerpt: Chapter 1 examines the actions of drug companies in raising prescription drug prices in the United States, as well as the effects of these actions on the Federal and state budgets, and on American families. Chapter 2 addresses frequently asked questions about government and private-sector policies that affect drug prices and availability. Among the prescription drug topics covered are federally funded research and development, regulation of direct-to-consumer advertising, legal restrictions on reimportation, and federal price negotiation. The 340B Drug Pricing Program requires drug manufacturers to sell outpatient drugs at discounted prices to covered entitiesâeligible clinics, hospitals, and othersâin order to have their drugs covered by Medicaid. Covered entities are only allowed to provide 340B drugs to certain eligible patients. Chapter 3 reviews the Health Resources and Services Administration's (HRSA) oversight of the 340B Program to ensure compliance with program rules. In 2017, nearly 60% of U.S. adults aged 18â64 reported being prescribed medication in the past 12 months. Approximately 70% of prescription medications carry out-of-pocket costs. Strategies to reduce prescription drug costs at the individual level are discussed in chapters 4 and 5. Each year, Americans pay more for prescription drugs, and rising drug prices have a disproportionate impact on older Americans. Chapter 6 examines the history of rising drug prices for the brand-name drugs most commonly prescribed for seniors. Generic drugsâcopies of brand-name drugsâlead to significant cost savings. Before a generic drug can be marketed, FDA must approve the generic drug application. According to FDA, applications go through an average of three cycles of review before being approved, which may take years. Chapter 7 examines 1) the first review cycle approval rate of generic drug applications in recent years and factors that may have contributed to whether applications were approved; and 2) changes FDA has made to increase the first review cycle approval rate.
Book Synopsis Prescription Drugs by : Sarah F. Jaggar
Download or read book Prescription Drugs written by Sarah F. Jaggar and published by . This book was released on 1994 with total page 12 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis Prescription Drug Price Comparisons by : David J. Cantor
Download or read book Prescription Drug Price Comparisons written by David J. Cantor and published by . This book was released on 1998 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis International Drug Price Comparisons by : Fredrik Andersson
Download or read book International Drug Price Comparisons written by Fredrik Andersson and published by . This book was released on 1992 with total page 36 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis Prescription Drug Price Comparisons by : David J. Cantor
Download or read book Prescription Drug Price Comparisons written by David J. Cantor and published by . This book was released on 1998 with total page 6 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis A Comparison of International Drug Prices by : Thomas J. McLaughlin
Download or read book A Comparison of International Drug Prices written by Thomas J. McLaughlin and published by . This book was released on 1994 with total page 16 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis Prescription Drugs by : U S Government Accountability Office (G
Download or read book Prescription Drugs written by U S Government Accountability Office (G and published by BiblioGov. This book was released on 2013-06 with total page 46 pages. Available in PDF, EPUB and Kindle. Book excerpt: Pursuant to a congressional request, GAO provided information on the cost of prescription drug products, focusing on: (1) domestic and foreign price comparisons of identical prescription drugs; and (2) causes for documented price differentials. GAO found that: (1) manufacturers' prices for identical prescription drugs are generally higher in the United States than in Canada; (2) differences in U.S. and Canadian drug prices can be attributed to Canadian price regulations, reimbursement practices, and price controls; (3) manufacturers' research, development, marketing, production, and distribution costs are the same for identical drugs, but manufacturers charge U.S. wholesalers substantially more for the same drugs; (4) 81 percent of the drugs reviewed were more expensive in the United States and prices averaged 32 percent more; (5) Canadian regulations force manufacturers to accept cost reviews for new drugs and restrain prices for existing drugs; (6) Canadian provincial governments' containment of manufacturers' price setting discretion, liberal reimbursement policy, and power over adding or removing drugs from the reimbursable list results in concentrated buying power and low prices; and (7) there is some dispute over whether similar U.S. regulation and price controls would effectively control drug prices while sufficiently encouraging research and development of new and innovative drug products.
Download or read book Prescription Drugs written by and published by . This book was released on 2014 with total page 28 pages. Available in PDF, EPUB and Kindle. Book excerpt: In 2011, federal spending for prescription drugs by DOD, Medicaid, and Medicare Part D totaled $71.2 billion, representing about 85 percent of all federal prescription drug expenditures, for about 114.4 million beneficiaries. Each program reimbursed retail pharmacies for outpatient prescriptions filled at these pharmacies by their beneficiaries. GAO was asked to compare prices paid for prescription drugs across federal programs. This report compares retail reimbursement prices paid by DOD, Medicaid, and Medicare Part D for a sample of prescription drugs and describes factors affecting these prices. Using agency data for the third quarter of 2010 (the most recent data available at the time of GAO's analysis), GAO selected a sample of 50 high-utilization and 50 high-expenditure drugs; after accounting for overlap between the two groups, the final sample contained 78 drugs. GAO calculated average gross unit prices paid to pharmacies by each program by adding total program-paid and beneficiary-paid amounts and dividing by total utilization for each drug, the entire sample, and the subsets of brand-name and generic drugs. GAO calculated net unit prices paid by each program by subtracting all agency-reported beneficiary-paid amounts, rebates, refunds, and other price concessions from the gross unit prices. GAO also interviewed DOD, Medicaid, and Medicare Part D officials and reviewed literature describing factors affecting drug prices.
Book Synopsis WHO guideline on country pharmaceutical pricing policies by :
Download or read book WHO guideline on country pharmaceutical pricing policies written by and published by World Health Organization. This book was released on 2020-09-29 with total page 70 pages. Available in PDF, EPUB and Kindle. Book excerpt: In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems' ability to provide population-wide access to essential medicines. Pharmaceutical pricing policies need to be carefully planned, carried out, and regularly checked and revised according to changing conditions. Strong, well-thought-out policies can guide well-informed and balanced decisions to achieve affordable access to essential health products. This guideline replaces the 2015 WHO guideline on country pharmaceutical pricing policies, revised to reflect the growing body of literature since the last evidence review in 2010. This update also recognizes country experiences in managing the prices of pharmaceutical products.
Book Synopsis Prescription Drug Pricing in the 8th Congressional District in Michigan by :
Download or read book Prescription Drug Pricing in the 8th Congressional District in Michigan written by and published by . This book was released on 1999 with total page 16 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis Generic Drugs in Canada by : Canada. Patented Medicine Prices Review Board
Download or read book Generic Drugs in Canada written by Canada. Patented Medicine Prices Review Board and published by . This book was released on 2011 with total page 11 pages. Available in PDF, EPUB and Kindle. Book excerpt: The Patented Medicine Prices Review Board (PMPRB) is an independent quasi-judicial body established by Parliament in 1987. The PMPRB has a dual role: to ensure that prices at which patentees sell their patented medicines in Canada are not excessive; and to report on pharmaceutical trends of all medicines and R & D spending by patentees. The National Prescription Drug Utilization Information System (NPDUIS) provides critical analyses of drug price, utilization, and cost trends in Canada to support drug plan policy decision-making for participating federal, provincial, and territorial governments. This study compares the 2008 prices of prescription generic drug products in Canada to prices in other industrialized countries. It also estimates the potential savings that might be realized by public drug reimbursement programs if Canadian generic prices were brought into line with foreign prices.--Document.
